Inicio › Cáncer metastásico › Washington
Ensayos clínicos de Cáncer metastásico en Washington
49 estudios sobre Cáncer metastásico buscan participantes en Washington.
Ciudades en Washington
- Seattle39 estudios
- Tacoma10 estudios
- Kirkland7 estudios
- Vancouver4 estudios
- Spokane Valley4 estudios
- Renton3 estudios
- Spokane3 estudios
- Kennewick3 estudios
Texto oficial del estudio (inglés)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Swedish Cancer Institute Medical Oncology, Edmonds
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06270706Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Swedish Cancer Institute-Edmonds, Edmonds
- Swedish Cancer Institute-Issaquah, Issaquah
- Providence Regional Cancer System-Lacey, Lacey
- y 4 más
ReclutandoFase 2
Todas las edades · Todos los sexos · Actualizado el 12 nov 2026 · NCT05564377Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04886804A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Virginia Mason Medical Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- MultiCare Regional Cancer Center, Auburn
- MultiCare Regional Cancer Center, Gig Harbor
- MultiCare Regional Cancer Center, Puyallup
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06216301ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07007559Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Virginia Mason Medical Center, Seattle
- University of Washington Fred Hutchinson Cancer Center, Seattle
- Northwest Cancer Specialists, Vancouver
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07562152A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT05384626A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Swedish Cancer Institute - Edmonds, Edmonds
- Providence Regional Cancer Partnership, Everett
- UW Medicine Valley Medical Center, Renton
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Swedish Cancer Institute - Edmonds, Edmonds
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07213804A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Swedish Cancer Institute - Edmonds, Edmonds
- Kadlec Clinic Hematology and Oncology, Kennewick
- Swedish Medical Center, Seattle
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT06943755A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Fred Hutchinson Cancer Center / University of Washington, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT04657068Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- MultiCare Tacoma General Hospital, Tacoma
ReclutandoEstudio observacional
2 Months · Todos los sexos · Actualizado el 22 oct 2026 · NCT02474160A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06521554AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Seattle
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06989437Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06757634A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Fred Hutchinson Cancer Center ( Site 0013), Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06863272Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Fred Hutchinson Cancer Center, Seattle
- University Of Washington Medical Center, Seattle
- Northwest Cancer Specialists, P.C., Vancouver
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07227415Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Northwest Cancer Specialists, P.C., Vancouver
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222566Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Northwest Medical Specialties, PLLC, Bonney Lake
- Swedish Cancer Institute - Edmonds Campus, Edmonds
- Swedish Medical Center - Edmonds, Edmonds
- y 13 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222800A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06234605The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Research Site, Puyallup
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07205822Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Swedish Cancer Institute, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Tacoma
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06103864A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- University of Washington / Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT05118789SLV-154 Treatment of Advanced Cancers
- University of Washington / Fred Hutchinson Cancer Center, Seattle
- Northwest Medical Specialties, PLLC, Tacoma
ReclutandoFase 1
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06771219Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Cancer Care Northwest-1 (601 S. Sherman), Spokane
- Cancer Care Northwest_2 (605 E. Holland), Spokane
- Cancer Care Northwest, Spokane Valley
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06072612A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
- Fred Hutchinson Cancer Research Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT06803680Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04515810Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT05687110Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Kennewick
- Research Site, Seattle
ReclutandoFase 3
Edades de 18 en adelante · Mujeres · Actualizado el 29 jul 2026 · NCT07044336A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Swedish Cancer Institute, Edmonds
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jul 2026 · NCT05719558Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT05098210Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Puget Sound Health Care System, Seattle
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 15 jun 2026 · NCT05422911BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Fred Hutchinson Cancer Center, Seattle
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jun 2026 · NCT06917079Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Virginia Mason Medical Center, Seattle
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 may 2026 · NCT05379985De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.